Cellular uptake of beta2M and AGE-beta2M in synovial fibroblasts and macrophages

Kalisha D O'Neill1, Neal X Chen, Mu Wang

  • 1Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Abstract

Insights

Advanced glycation end products of beta-2-microglobulin (AGE-beta(2)M) and native beta-2-microglobulin (beta(2)M) are taken up differently by cells. This explains variable responses in dialysis patients with beta(2)M amyloidosis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Medical Science

Background:

  • Beta-2-microglobulin (beta(2)M) amyloidosis is a debilitating joint disease in dialysis patients.
  • Amyloid deposits consist of beta(2)M and AGE-beta(2)M, which elicit different cellular responses.
  • Native beta(2)M affects synovial fibroblasts, while AGE-beta(2)M impacts monocyte/macrophages.

Purpose of the Study:

  • To investigate the distinct cellular uptake mechanisms of beta(2)M and AGE-beta(2)M.
  • To understand the variable cellular responses to these two forms of beta(2)M.

Main Methods:

  • Labeling AGE-beta(2)M with Cy5 and beta(2)M with Texas Red (TR).
  • Utilizing live cell imaging and confocal microscopy to track uptake in human synovial fibroblasts and monocyte/macrophages.
  • Employing competitive inhibition assays with AGE-BSA.

Main Results:

  • AGE-beta(2)M was rapidly internalized into endosome-like structures in synovial fibroblasts, suggesting receptor-mediated uptake.
  • Native beta(2)M showed minimal uptake in synovial fibroblasts, accumulating on the cell surface.
  • Both AGE-beta(2)M and beta(2)M exhibited similar uptake patterns and kinetics in monocyte/macrophages.

Conclusions:

  • Beta(2)M and AGE-beta(2)M utilize different endocytosis pathways in human synovial fibroblasts.
  • Distinct cellular uptake mechanisms in monocytes/macrophages were observed.
  • These findings provide a potential explanation for differential cell culture results in beta(2)M amyloidosis research.

Related Concept Videos